Access Engagement & HTA Head

Role Purpose Reporting to the Market Access Director, this role support J&J Innovative Medicine Saudi Arabia s access engagement and HTA strategy, positioning the portfolio for success within an evolving Saudi healthcare system. As a customer- and stakeholder-facing Market Access leader, the role connects policy, HTA and emerging healthcare models with field access execution. Working closely with HEMAR Leads, SAM, Pricing & Tender, Medical, Commercial and Regulatory teams, the role translates external developments into actionable portfolio and account strategies. The role is accountable for three strategic priorities: • Shape the environment through HTA, policy and value dialogue. • Build for the emerging healthcare model by engaging new entities and developing innovative access solutions. • Move access closer to customers through differentiated, insight-driven field engagement. Key Responsibilities • Shape policy and HTA dialogue with MoH, CNHI/CHTA and CHI , anticipating evolving evidence, economic and value requirements and translating them into portfolio, brand and evidence plans. • Lead the KSA portfolio HTA and Economic Evaluation Study strategy , including Saudi-adapted economic models, local epidemiology, real-world evidence and appropriate comparators, in close partnership with HEMAR and Medical Affairs. • Monitor major healthcare-system developments, including Vision 2030 healthcare transformation, financing reform and privatization , and translate them into clear access implications, risks and opportunities for the leadership team. • Activate relevant priorities across HTA and EES activities, strengthening strategic contracting, price protection, value and pricing policy, portfolio value narratives and stakeholder prioritization. • Represent J&J Innovative Medicine credibly in appropriate policy forums, industry associations and public-private initiatives . • Establish and deepen strategic relationships with emerging healthcare stakeholders, including CNHI, HHC and healthcare clusters, provider economic functions, and purchasing/contracting organizations . • Serve as a key Market Access interface with transforming the healthcare ecosystem, identifying changes early and translating them into actionable access opportunities. • Support developing the innovative access solutions including value-based agreements, outcomes-based contracting, innovative financing, early-access and managed-entry approaches , aligned with evolving purchasing and reimbursement models. • Develop high-level health-transformation plans reflecting HHC and cluster priorities and connect these plans with portfolio priorities and launch sequencing. • Apply an integrated planning discipline to strategic access initiatives, with quantified ambition, clear DRI ownership, defined milestones and regular continue/refine/scale/stop decisions . • Partner with Medical, Commercial, Regulatory, HEMAR and other Access team members to align portfolio strategies with emerging pathways and strengthen organizational readiness for the new healthcare model. • Build a differentiated customer-facing access engagement model , segmenting stakeholders according to influence, strategic importance and access impact. • Expand Market Access engagement beyond traditional purchasing stakeholders to include cluster leadership, finance, contracting, HTA committees, insurers and other emerging access decisionmakers . • Establish a disciplined after-action review approach to evaluate stakeholder reach, conversion, follow-through and value-message effectiveness , translating insights into future engagement priorities. • Connect national access achievements with account-level execution, ensuring formulary and tender wins translate into sustainable patient access and uptake . Key Accountabilities / Measures of Success Success should be measured across impact, execution and customer engagement , rather than activity volume alone: HTA & Environment Shaping • HTA/EES portfolio plan delivered against agreed milestones. • External evidence requirements systematically incorporated into evidence and brand planning. • Quality and timeliness of HTA/value submissions and strategic narratives. • Progress against prioritized policy and HTA-shaping initiatives. Health Transformation • Strategic engagement plans established for priority emerging entities and healthcare clusters. • Identified transformation opportunities converted into executable access initiatives. • Innovative contracting/access concepts progressed through defined stage gates. • Account transformation plans integrated with priority brands and launches. • Bachelor s degree in pharmacy, life sciences, medicine, health economics or a related field; an advanced degree (MSc, MBA, MPH, PharmD or health economics) is preferred. • 6-10+ years in pharmaceutical or healthcare roles with a strong track record in market access, HEMAR, health policy or health-system transformation; KSA experience is essential. • Deep working knowledge of the Saudi health system and Vision 2030 - CNHI, HHC and clusters, MoH, SFDA, CHI and of HTA / EES, formulary and NUPCO tender pathways. • Demonstrated ability to build senior external relationships and deliver access outcomes across specialty therapy areas. • Fluency in Arabic and English